<code id='E93B6D155D'></code><style id='E93B6D155D'></style>
    • <acronym id='E93B6D155D'></acronym>
      <center id='E93B6D155D'><center id='E93B6D155D'><tfoot id='E93B6D155D'></tfoot></center><abbr id='E93B6D155D'><dir id='E93B6D155D'><tfoot id='E93B6D155D'></tfoot><noframes id='E93B6D155D'>

    • <optgroup id='E93B6D155D'><strike id='E93B6D155D'><sup id='E93B6D155D'></sup></strike><code id='E93B6D155D'></code></optgroup>
        1. <b id='E93B6D155D'><label id='E93B6D155D'><select id='E93B6D155D'><dt id='E93B6D155D'><span id='E93B6D155D'></span></dt></select></label></b><u id='E93B6D155D'></u>
          <i id='E93B6D155D'><strike id='E93B6D155D'><tt id='E93B6D155D'><pre id='E93B6D155D'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:154
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          CRISPR technology availability, affordability needs to be expanded
          CRISPR technology availability, affordability needs to be expanded

          Fromleft,STAT'sJasonMast;JuliaVitarello,founder&CEOofMila’sMiracleFoundation;andFyodorUrnov,agen

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Erich Jarvis studies song birds to learn about human stuttering

          Starlingsperchonapowerlineinthemorningsun.PATRICKPLEUL/DPA/AFPviaGettyImagesAsymphonyofsynapsesfires